HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tsutomu Nobori Selected Research

formycin diphosphate (FDP)

8/2011Prospective evaluation of hemostatic abnormalities in overt DIC due to various underlying diseases.
11/2008Elevated levels of soluble fibrin in patients with venous thromboembolism.
7/2005Usefulness of fully automated measurement of reticulated platelets using whole blood.
1/2005Haemostatic abnormalities and thrombotic disorders in malignant lymphoma.
4/2003[Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
3/2002[Criteria for diagnosing DIC].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tsutomu Nobori Research Topics

Disease

27Neoplasms (Cancer)
08/2015 - 04/2002
25Disseminated Intravascular Coagulation
01/2013 - 03/2002
17Thrombosis (Thrombus)
01/2012 - 03/2002
10Venous Thrombosis (Deep-Vein Thrombosis)
02/2012 - 08/2004
9Heart Failure
01/2016 - 04/2003
9Infections
01/2013 - 06/2002
8Hepatocellular Carcinoma (Hepatoma)
10/2014 - 03/2005
7Pulmonary Embolism
10/2011 - 08/2004
6Liver Diseases (Liver Disease)
04/2013 - 03/2005
6Thrombotic Microangiopathies
03/2013 - 01/2008
6Communicable Diseases (Infectious Diseases)
05/2012 - 04/2003
5Thrombotic Thrombocytopenic Purpura
05/2012 - 05/2002
5Sepsis (Septicemia)
06/2009 - 06/2002
5Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
01/2007 - 08/2004
5Lymphoma (Lymphomas)
01/2006 - 01/2003
4Thrombocytopenia (Thrombopenia)
01/2016 - 01/2008
4Insulin Resistance
01/2015 - 01/2005
4Wounds and Injuries (Trauma)
08/2011 - 09/2003
3Neoplasm Metastasis (Metastasis)
09/2014 - 09/2002
3Liver Cirrhosis (Hepatic Cirrhosis)
08/2014 - 03/2005
3Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
03/2013 - 08/2004
3Hyperlipidemias (Hyperlipidemia)
11/2012 - 01/2005
3Fibrosis (Cirrhosis)
04/2010 - 06/2004
3Venous Thromboembolism
11/2008 - 01/2005
3Aplastic Anemia (Anemia, Hypoplastic)
01/2006 - 07/2005
2Endocarditis
01/2016 - 06/2009
2Colonic Neoplasms (Colon Cancer)
09/2014 - 11/2006
2Obstructive Jaundice (Cholestatic Jaundice)
06/2013 - 04/2005
2Chronic Hepatitis (Chronic Active Hepatitis)
04/2013 - 03/2005
2Thrombophilia
03/2012 - 04/2003
2Burns
08/2011 - 10/2005
2Stomach Neoplasms (Stomach Cancer)
04/2009 - 12/2004
2Neuroblastoma
04/2009 - 06/2004
2Rheumatoid Arthritis
04/2008 - 06/2002
2Inflammation (Inflammations)
08/2006 - 11/2005

Drug/Important Bio-Agent (IBA)

26Dacarbazine (DIC)FDA LinkGeneric
01/2013 - 03/2002
12FibrinIBA
11/2012 - 03/2002
11Messenger RNA (mRNA)IBA
09/2014 - 04/2003
11fibrin fragment D (D-dimer)IBA
09/2012 - 01/2005
9Proteins (Proteins, Gene)FDA Link
01/2015 - 10/2004
9Hemostatics (Antihemorrhagics)IBA
02/2012 - 01/2003
7Fibrinogen (Factor I)FDA Link
09/2012 - 03/2002
6von Willebrand FactorIBA
03/2013 - 01/2005
6formycin diphosphate (FDP)IBA
08/2011 - 03/2002
6Thromboplastin (Tissue Factor)IBA
01/2006 - 04/2002
5oxidized low density lipoproteinIBA
11/2012 - 07/2003
5thiamine triphosphorate (TTP)IBA
05/2012 - 05/2002
5Inosine Triphosphate (ITP)IBA
01/2007 - 08/2004
4Biomarkers (Surrogate Marker)IBA
08/2015 - 04/2013
4DisintegrinsIBA
04/2014 - 01/2007
4ThrombospondinsIBA
04/2014 - 01/2007
4Metalloproteases (Metalloproteinases)IBA
04/2014 - 01/2007
4ThrombinFDA Link
11/2012 - 07/2002
4AntigensIBA
05/2012 - 07/2004
4Protein SIBA
03/2012 - 06/2010
4LipidsIBA
04/2010 - 07/2003
4Triglycerides (Triacylglycerol)IBA
04/2010 - 01/2005
45'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
01/2009 - 06/2003
4EnzymesIBA
11/2007 - 04/2002
4Fibrin Fibrinogen Degradation ProductsIBA
10/2005 - 04/2003
3Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 06/2009
3AdiponectinIBA
01/2015 - 01/2005
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2014 - 04/2008
3AntithrombinsIBA
03/2012 - 07/2002
3Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
04/2010 - 04/2003
3LDL Lipoproteins (beta Lipoproteins)IBA
04/2010 - 07/2003
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2010 - 04/2003
3CholesterolIBA
04/2010 - 01/2005
3C-Reactive ProteinIBA
08/2006 - 07/2005
3Lipoproteins (Lipoprotein)IBA
04/2005 - 07/2003
3Thomsen-Friedenreich antigenIBA
01/2005 - 07/2004
3Angiotensin Receptor AntagonistsIBA
12/2004 - 04/2003
2LigandsIBA
10/2014 - 01/2013
2Pharmaceutical PreparationsIBA
11/2013 - 11/2002
2Prothrombin (Factor II)IBA
06/2013 - 08/2004
2AntibodiesIBA
06/2013 - 08/2004
2Antiphospholipid AntibodiesIBA
03/2013 - 01/2013
2Phosphotransferases (Kinase)IBA
01/2013 - 04/2009
2CytokinesIBA
01/2013 - 01/2005
2Indicators and Reagents (Reagents)IBA
11/2012 - 03/2002
2prothrombin fragment 1IBA
11/2012 - 07/2008
2fibrinmonomerIBA
09/2012 - 08/2011
2Protein CIBA
03/2012 - 01/2005
2Fondaparinux (Arixtra)FDA Link
02/2012 - 10/2011
2protein S TokushimaIBA
01/2012 - 09/2010
2ThrombomodulinIBA
08/2011 - 01/2005
2VLDL LipoproteinsIBA
04/2010 - 01/2005
2DNA (Deoxyribonucleic Acid)IBA
06/2009 - 04/2005
2Myeloblastin (Proteinase 3)IBA
04/2008 - 08/2006
2N 30IBA
02/2008 - 08/2004
2purineIBA
11/2007 - 04/2005
2Pancreatic Elastase (Elastase)IBA
10/2005 - 01/2005
2Glucose (Dextrose)FDA LinkGeneric
03/2005 - 01/2005

Therapy/Procedure

7Liver Transplantation
01/2016 - 08/2005
7Drug Therapy (Chemotherapy)
08/2015 - 07/2005
7Therapeutics
11/2013 - 06/2007
2Splenectomy
01/2016 - 04/2014
2Knee Replacement Arthroplasty (Total Knee Replacement)
02/2012 - 10/2011
2Plasma Exchange
07/2011 - 05/2002
2Catheters
06/2007 - 04/2006